Genentech's BD Exec Spotlights Neuroscience Pipeline
Executive Summary
Thomas Zioncheck, business development executive at Genentech, outlines the company's upcoming R&D goals and early-stage partnering approach outside of oncology. He highlights Genentech's multiple sclerosis portfolio and adds color to its R&D strategy for products targeting Alzheimer's disease and other neurological conditions.